Acute nicotine effects on auditory sensory memory in tacrine-treated and nontreated patients with Alzheimer's disease: An event-related potential study

The auditory mismatch negativity (MMN) event-related brain potential (ERP) reflects the storage of information in acoustic sensory memory. Thirteen patients with Alzheimer's disease (AD), 6 receiving treatment with the cholinesterase inhibitor, tacrine [tetrahydroaminoacridine (THA)], and 7 rec...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmacology, biochemistry and behavior biochemistry and behavior, 2002-05, Vol.72 (1), p.457-464
Hauptverfasser: Engeland, C., Mahoney, C., Mohr, E., Ilivitsky, V., Knott, Verner J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 464
container_issue 1
container_start_page 457
container_title Pharmacology, biochemistry and behavior
container_volume 72
creator Engeland, C.
Mahoney, C.
Mohr, E.
Ilivitsky, V.
Knott, Verner J.
description The auditory mismatch negativity (MMN) event-related brain potential (ERP) reflects the storage of information in acoustic sensory memory. Thirteen patients with Alzheimer's disease (AD), 6 receiving treatment with the cholinesterase inhibitor, tacrine [tetrahydroaminoacridine (THA)], and 7 receiving no treatment, were administered 2 mg of nicotine polacrilex and placebo. MMNs were recorded with 1- and 3-s interstimulus intervals (ISIs) during pre- and post-placebo/nicotine administration. Amplitudes decreased from pre- to post-placebo recordings in nontreated patients but remained stable in THA-treated patients. Comparison of pre- and post-nicotine MMNs found amplitude increases with nicotine in nontreated but not in THA-treated patients. MMN latencies were shortened by nicotine in both treatment groups. These exploratory findings suggest that nicotine-improved strength of acoustic sensory memory traces and speed of acoustic sensory discrimination in AD are differentially affected by chronic tacrine treatment.
doi_str_mv 10.1016/S0091-3057(02)00711-6
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_71567267</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0091305702007116</els_id><sourcerecordid>71567267</sourcerecordid><originalsourceid>FETCH-LOGICAL-c345t-11d2c2dcef881123be65555cdad18e99d0e9986f64721b0c79914d3d027164153</originalsourceid><addsrcrecordid>eNpFkc9u1DAQxi0EokvhEUC-8O8QmHESO-kFrSoolSr1AJwtrz1RjRJnsZ2i5UV4XbzdbZnDfBrpNyPN9zH2EuEDAsqP3wB6rGpo1TsQ7wEUYiUfsRV2qq5aVOoxWz0gJ-xZSj8BoBFSPWUniD1AJ2DF_q7tkokHb-fsA3EaBrI58Tlwszif57jjiULa60TTXnzg2dhY6CpHMpkcN8HxMIf7cWuyp1Cu_Pb5hq_HPzfkJ4pvE3c-kUl0xteB021hqkjjYWfOZfRm5CkvbvecPRnMmOjFUU_Zjy-fv59_ra6uLy7P11eVrZs2V4hOWOEsDV2HKOoNybaUdcZhR33voLRODrJRAjdgVd9j42oHQqFssK1P2ZvD3W2cfy2Usp58sjSOJtC8JK2wlaqYVsBXR3DZTOT0NvrJxJ2-t7IAr4-ASdaMQzTB-vSfa9pGYtcU7tOBo_LWraeoky1uWXI-Fuu1m71G0PuQ9V3Iep-gBqHvQtay_gfU3JpW</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71567267</pqid></control><display><type>article</type><title>Acute nicotine effects on auditory sensory memory in tacrine-treated and nontreated patients with Alzheimer's disease: An event-related potential study</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Engeland, C. ; Mahoney, C. ; Mohr, E. ; Ilivitsky, V. ; Knott, Verner J.</creator><creatorcontrib>Engeland, C. ; Mahoney, C. ; Mohr, E. ; Ilivitsky, V. ; Knott, Verner J.</creatorcontrib><description>The auditory mismatch negativity (MMN) event-related brain potential (ERP) reflects the storage of information in acoustic sensory memory. Thirteen patients with Alzheimer's disease (AD), 6 receiving treatment with the cholinesterase inhibitor, tacrine [tetrahydroaminoacridine (THA)], and 7 receiving no treatment, were administered 2 mg of nicotine polacrilex and placebo. MMNs were recorded with 1- and 3-s interstimulus intervals (ISIs) during pre- and post-placebo/nicotine administration. Amplitudes decreased from pre- to post-placebo recordings in nontreated patients but remained stable in THA-treated patients. Comparison of pre- and post-nicotine MMNs found amplitude increases with nicotine in nontreated but not in THA-treated patients. MMN latencies were shortened by nicotine in both treatment groups. These exploratory findings suggest that nicotine-improved strength of acoustic sensory memory traces and speed of acoustic sensory discrimination in AD are differentially affected by chronic tacrine treatment.</description><identifier>ISSN: 0091-3057</identifier><identifier>EISSN: 1873-5177</identifier><identifier>DOI: 10.1016/S0091-3057(02)00711-6</identifier><identifier>PMID: 11900820</identifier><identifier>CODEN: PBBHAU</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Acetylcholine ; Acoustic Stimulation - methods ; Aged ; Aged, 80 and over ; Alzheimer Disease - drug therapy ; Alzheimer Disease - physiopathology ; Alzheimer Disease - psychology ; Alzheimer's disease ; Analysis of Variance ; Biological and medical sciences ; Cholinergic system ; Cross-Over Studies ; Double-Blind Method ; ERPs ; Event-related potentials ; Evoked Potentials, Auditory - drug effects ; Evoked Potentials, Auditory - physiology ; Female ; Humans ; Male ; Medical sciences ; Memory - drug effects ; Memory - physiology ; Middle Aged ; Mismatch negativity ; MMN ; Neuropharmacology ; Neurotransmitters. Neurotransmission. Receptors ; Nicotine ; Nicotine - administration &amp; dosage ; Pharmacology. Drug treatments ; Sensory memory ; Tacrine ; Tacrine - therapeutic use</subject><ispartof>Pharmacology, biochemistry and behavior, 2002-05, Vol.72 (1), p.457-464</ispartof><rights>2002 Elsevier Science Inc.</rights><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c345t-11d2c2dcef881123be65555cdad18e99d0e9986f64721b0c79914d3d027164153</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0091-3057(02)00711-6$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14546184$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11900820$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Engeland, C.</creatorcontrib><creatorcontrib>Mahoney, C.</creatorcontrib><creatorcontrib>Mohr, E.</creatorcontrib><creatorcontrib>Ilivitsky, V.</creatorcontrib><creatorcontrib>Knott, Verner J.</creatorcontrib><title>Acute nicotine effects on auditory sensory memory in tacrine-treated and nontreated patients with Alzheimer's disease: An event-related potential study</title><title>Pharmacology, biochemistry and behavior</title><addtitle>Pharmacol Biochem Behav</addtitle><description>The auditory mismatch negativity (MMN) event-related brain potential (ERP) reflects the storage of information in acoustic sensory memory. Thirteen patients with Alzheimer's disease (AD), 6 receiving treatment with the cholinesterase inhibitor, tacrine [tetrahydroaminoacridine (THA)], and 7 receiving no treatment, were administered 2 mg of nicotine polacrilex and placebo. MMNs were recorded with 1- and 3-s interstimulus intervals (ISIs) during pre- and post-placebo/nicotine administration. Amplitudes decreased from pre- to post-placebo recordings in nontreated patients but remained stable in THA-treated patients. Comparison of pre- and post-nicotine MMNs found amplitude increases with nicotine in nontreated but not in THA-treated patients. MMN latencies were shortened by nicotine in both treatment groups. These exploratory findings suggest that nicotine-improved strength of acoustic sensory memory traces and speed of acoustic sensory discrimination in AD are differentially affected by chronic tacrine treatment.</description><subject>Acetylcholine</subject><subject>Acoustic Stimulation - methods</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Alzheimer Disease - drug therapy</subject><subject>Alzheimer Disease - physiopathology</subject><subject>Alzheimer Disease - psychology</subject><subject>Alzheimer's disease</subject><subject>Analysis of Variance</subject><subject>Biological and medical sciences</subject><subject>Cholinergic system</subject><subject>Cross-Over Studies</subject><subject>Double-Blind Method</subject><subject>ERPs</subject><subject>Event-related potentials</subject><subject>Evoked Potentials, Auditory - drug effects</subject><subject>Evoked Potentials, Auditory - physiology</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Memory - drug effects</subject><subject>Memory - physiology</subject><subject>Middle Aged</subject><subject>Mismatch negativity</subject><subject>MMN</subject><subject>Neuropharmacology</subject><subject>Neurotransmitters. Neurotransmission. Receptors</subject><subject>Nicotine</subject><subject>Nicotine - administration &amp; dosage</subject><subject>Pharmacology. Drug treatments</subject><subject>Sensory memory</subject><subject>Tacrine</subject><subject>Tacrine - therapeutic use</subject><issn>0091-3057</issn><issn>1873-5177</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkc9u1DAQxi0EokvhEUC-8O8QmHESO-kFrSoolSr1AJwtrz1RjRJnsZ2i5UV4XbzdbZnDfBrpNyPN9zH2EuEDAsqP3wB6rGpo1TsQ7wEUYiUfsRV2qq5aVOoxWz0gJ-xZSj8BoBFSPWUniD1AJ2DF_q7tkokHb-fsA3EaBrI58Tlwszif57jjiULa60TTXnzg2dhY6CpHMpkcN8HxMIf7cWuyp1Cu_Pb5hq_HPzfkJ4pvE3c-kUl0xteB021hqkjjYWfOZfRm5CkvbvecPRnMmOjFUU_Zjy-fv59_ra6uLy7P11eVrZs2V4hOWOEsDV2HKOoNybaUdcZhR33voLRODrJRAjdgVd9j42oHQqFssK1P2ZvD3W2cfy2Usp58sjSOJtC8JK2wlaqYVsBXR3DZTOT0NvrJxJ2-t7IAr4-ASdaMQzTB-vSfa9pGYtcU7tOBo_LWraeoky1uWXI-Fuu1m71G0PuQ9V3Iep-gBqHvQtay_gfU3JpW</recordid><startdate>20020501</startdate><enddate>20020501</enddate><creator>Engeland, C.</creator><creator>Mahoney, C.</creator><creator>Mohr, E.</creator><creator>Ilivitsky, V.</creator><creator>Knott, Verner J.</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20020501</creationdate><title>Acute nicotine effects on auditory sensory memory in tacrine-treated and nontreated patients with Alzheimer's disease: An event-related potential study</title><author>Engeland, C. ; Mahoney, C. ; Mohr, E. ; Ilivitsky, V. ; Knott, Verner J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c345t-11d2c2dcef881123be65555cdad18e99d0e9986f64721b0c79914d3d027164153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Acetylcholine</topic><topic>Acoustic Stimulation - methods</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Alzheimer Disease - drug therapy</topic><topic>Alzheimer Disease - physiopathology</topic><topic>Alzheimer Disease - psychology</topic><topic>Alzheimer's disease</topic><topic>Analysis of Variance</topic><topic>Biological and medical sciences</topic><topic>Cholinergic system</topic><topic>Cross-Over Studies</topic><topic>Double-Blind Method</topic><topic>ERPs</topic><topic>Event-related potentials</topic><topic>Evoked Potentials, Auditory - drug effects</topic><topic>Evoked Potentials, Auditory - physiology</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Memory - drug effects</topic><topic>Memory - physiology</topic><topic>Middle Aged</topic><topic>Mismatch negativity</topic><topic>MMN</topic><topic>Neuropharmacology</topic><topic>Neurotransmitters. Neurotransmission. Receptors</topic><topic>Nicotine</topic><topic>Nicotine - administration &amp; dosage</topic><topic>Pharmacology. Drug treatments</topic><topic>Sensory memory</topic><topic>Tacrine</topic><topic>Tacrine - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Engeland, C.</creatorcontrib><creatorcontrib>Mahoney, C.</creatorcontrib><creatorcontrib>Mohr, E.</creatorcontrib><creatorcontrib>Ilivitsky, V.</creatorcontrib><creatorcontrib>Knott, Verner J.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmacology, biochemistry and behavior</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Engeland, C.</au><au>Mahoney, C.</au><au>Mohr, E.</au><au>Ilivitsky, V.</au><au>Knott, Verner J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Acute nicotine effects on auditory sensory memory in tacrine-treated and nontreated patients with Alzheimer's disease: An event-related potential study</atitle><jtitle>Pharmacology, biochemistry and behavior</jtitle><addtitle>Pharmacol Biochem Behav</addtitle><date>2002-05-01</date><risdate>2002</risdate><volume>72</volume><issue>1</issue><spage>457</spage><epage>464</epage><pages>457-464</pages><issn>0091-3057</issn><eissn>1873-5177</eissn><coden>PBBHAU</coden><abstract>The auditory mismatch negativity (MMN) event-related brain potential (ERP) reflects the storage of information in acoustic sensory memory. Thirteen patients with Alzheimer's disease (AD), 6 receiving treatment with the cholinesterase inhibitor, tacrine [tetrahydroaminoacridine (THA)], and 7 receiving no treatment, were administered 2 mg of nicotine polacrilex and placebo. MMNs were recorded with 1- and 3-s interstimulus intervals (ISIs) during pre- and post-placebo/nicotine administration. Amplitudes decreased from pre- to post-placebo recordings in nontreated patients but remained stable in THA-treated patients. Comparison of pre- and post-nicotine MMNs found amplitude increases with nicotine in nontreated but not in THA-treated patients. MMN latencies were shortened by nicotine in both treatment groups. These exploratory findings suggest that nicotine-improved strength of acoustic sensory memory traces and speed of acoustic sensory discrimination in AD are differentially affected by chronic tacrine treatment.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>11900820</pmid><doi>10.1016/S0091-3057(02)00711-6</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0091-3057
ispartof Pharmacology, biochemistry and behavior, 2002-05, Vol.72 (1), p.457-464
issn 0091-3057
1873-5177
language eng
recordid cdi_proquest_miscellaneous_71567267
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Acetylcholine
Acoustic Stimulation - methods
Aged
Aged, 80 and over
Alzheimer Disease - drug therapy
Alzheimer Disease - physiopathology
Alzheimer Disease - psychology
Alzheimer's disease
Analysis of Variance
Biological and medical sciences
Cholinergic system
Cross-Over Studies
Double-Blind Method
ERPs
Event-related potentials
Evoked Potentials, Auditory - drug effects
Evoked Potentials, Auditory - physiology
Female
Humans
Male
Medical sciences
Memory - drug effects
Memory - physiology
Middle Aged
Mismatch negativity
MMN
Neuropharmacology
Neurotransmitters. Neurotransmission. Receptors
Nicotine
Nicotine - administration & dosage
Pharmacology. Drug treatments
Sensory memory
Tacrine
Tacrine - therapeutic use
title Acute nicotine effects on auditory sensory memory in tacrine-treated and nontreated patients with Alzheimer's disease: An event-related potential study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T18%3A14%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Acute%20nicotine%20effects%20on%20auditory%20sensory%20memory%20in%20tacrine-treated%20and%20nontreated%20patients%20with%20Alzheimer's%20disease:%20An%20event-related%20potential%20study&rft.jtitle=Pharmacology,%20biochemistry%20and%20behavior&rft.au=Engeland,%20C.&rft.date=2002-05-01&rft.volume=72&rft.issue=1&rft.spage=457&rft.epage=464&rft.pages=457-464&rft.issn=0091-3057&rft.eissn=1873-5177&rft.coden=PBBHAU&rft_id=info:doi/10.1016/S0091-3057(02)00711-6&rft_dat=%3Cproquest_pubme%3E71567267%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71567267&rft_id=info:pmid/11900820&rft_els_id=S0091305702007116&rfr_iscdi=true